Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.

Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. Abstract Text:

    don c des jarlaisDon C Des Jarlais,kamyar arastehKamyar Arasteh,theresa perlisTheresa Perlis,holly haganHolly Hagan,abu abdul-quaderAbu Abdul-Quader,douglas d heckathornDouglas D Heckathorn,courtney mcknightCourtney McKnight,heidi bramsonHeidi Bramson,chris nemethChris Nemeth,lucia v torianLucia V Torian,samuel r friedmanSamuel R Friedman,

    OBJECTIVE: To compare HIV prevalence among injecting and non-injecting heroin and cocaine users in New York City. As HIV is efficiently transmitted through the sharing of drug-injecting equipment, HIV infection has historically been higher among injecting drug users. DESIGN: Two separate cross-sectional surveys, both with HIV counseling and testing and drug use and HIV risk behavior questionnaires. METHODS: Injecting and non-injecting heroin and cocaine users recruited at detoxification and methadone maintenance treatment from 2001-2004 (n = 2121) and recruited through respondent-driven sampling from a research storefront in 2004 (n = 448). RESULTS: In both studies, HIV prevalence was nearly identical among current injectors (injected in the last 6 months) and heroin and cocaine users who had never injected: 13% [95% confidence interval (CI), 12-15%] among current injectors and 12% (95% CI, 9-16%) among never-injectors in the drug treatment program study, and 15% (95% CI, 11-19%) among current injectors and 17% (95% CI, 12-21%) among never injectors in the respondent driven sampling storefront study. The 95% CIs overlapped in all gender and race/ethnicity subgroup comparisons of HIV prevalence in both studies. CONCLUSIONS: The very large HIV epidemic among drug users in New York City appears to be entering a new phase, in which sexual transmission is of increasing importance. Additional prevention programs are needed to address this transition.

    Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. Publishing Authors By Initials

    dc des jarlaisDC Des Jarlais,k arastehK Arasteh,t perlisT Perlis,h haganH Hagan,a abdul-quaderA Abdul-Quader,dd heckathornDD Heckathorn,c mcknightC McKnight,h bramsonH Bramson,c nemethC Nemeth,lv torianLV Torian,sr friedmanSR Friedman,

    For similar disorders of environmental origin: substance-related disorders research abstracts see: disorders of environmental origin: substance-related disorders research

    PUBMED ID PMID:

    MEDLINE DATE:

    Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: AIDS (London, England)

    VOLUME: 21

    Page Numbers: 231-5

    Journal Abbreviation: AIDS

    ISSN: 0269-9370

    DAY: 11

    MONTH: Jan

    YEAR: 2007

    Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8710219

    Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. Keywords Mesh Terms:

    KEYWORDS: Substance-Related Disorders

    MESH TERMS: epidemiology

    Chemical & Substance for Abstract: Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.

    AFFILIATION: Beth Israel Medical Center, New York, New York 10038, USA. dcdesjarla@aol.com

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NIDA

    GRANT: 5R01 DA003574

    ACRONYM: DA

    MEDLINETA: AIDS

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News